The efficacy and safety of valproic acid medications with controlled active ingredient release in adults in real clinical practice from the position of pharmacokinetic and pharmacogenetic approaches
Objective: to analyze the efficacy and tolerability of sustained-release sodium valproate (SV) in adult patients with focal or generalized epilepsy in real clinical practice in three regions (Krasnoyarsk, Moscow, and Samara) of the Russian Federation.Patients and methods. The investigation enrolled...
Main Authors: | P. N. Vlasov, N. V. Orekhova, M. V. Antonyuk, N. V. Filatova, N. A. Schnaider, D. V. Dmitrenko, S. N. Zobova, I. E. Poverennova, A. V. Yakunina, V. A. Kalinin, S. K. Zyryanov, I. F. Tishchenkova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2017-06-01
|
Series: | Nevrologiâ, Nejropsihiatriâ, Psihosomatika |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/721 |
Similar Items
-
Process of Personalized Prescription of Valproic Acid as the Main Element of the Management of Epilepsy
by: Elena N. Bochanova, et al.
Published: (2018-03-01) -
FREQUENCIES OF POLYMORPHISMS IN THE CYTOCHROME’S P450 GENES OF WARFARIN TRANSFORMATION IN A EUROPEAN POPULATION OF EASTERN SIBERIA
by: T. A. Bairova, et al.
Published: (2018-09-01) -
Influence of Pathogenic and Metabolic Genes on the Pharmacogenetics of Mood Disorders in Alzheimer’s Disease
by: Ramón Cacabelos, et al.
Published: (2021-04-01) -
GENETIC POLYMORPHISM OF CYTOCHROMES P450 2C9 AND 2C19 IN SLOVENIAN POPULATION
by: Darja Herman, et al.
Published: (2003-06-01) -
Lack of Major Involvement of Common CYP2C Gene Polymorphisms in the Risk of Developing Cross-Hypersensitivity to NSAIDs
by: Yolanda Macías, et al.
Published: (2021-09-01)